1-8 of 8
Susann M. Szmania
Close
Sort by
Journal Articles

Pretreatment Platelet Count Predicts the Outcome of Invasive Aspergillosis among Myeloma Patients Undergoing Myelosuppressive Chemotherapy

Yue-Jin Wen, Weizhi Zhao, Monica Grazziutti, Wen Ling, Jeanette Lee, Susann M Szmania, Frits van Rhee, Bart Barlogie, Elias J. Anaissie
Journal: Blood
Blood (2008) 112 (11): 4353.
https://doi.org/10.1182/blood.V112.11.4353.4353
Published: 2008
Journal Articles

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma

Jumei Shi, Guido J. Tricot, Tarun K. Garg, Priyangi A. Malaviarachchi, Susann M. Szmania, Rachel E. Kellum, Brian Storrie, Arend Mulder, John D. Shaughnessy, Jr, Bart Barlogie, Frits van Rhee
Journal: Blood
Blood (2008) 111 (3): 1309–1317.
https://doi.org/10.1182/blood-2007-03-078535
Published: 2008
Includes: Supplemental data
Journal Articles

A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.

Jumei Shi, MD, PhD, Guido J. Tricot, MD, PhD, Priyangi A. Malaviarachchi, Tarun K. Garg, PhD, Susann M. Szmania, Arend Mulder, PhD, John D. Shaughnessy, PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1525.
https://doi.org/10.1182/blood.V110.11.1525.1525
Published: 2007
Journal Articles

Bortezomib Down-Regulates HLA Class I and Enhances Natural Killer Cell Mediated Lysis of Myeloma.

Jumei Shi, MD, PhD, Tarun K. Garg, PhD, Rachel E. Kellum, BS, Susann M. Szmania, BS, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3498.
https://doi.org/10.1182/blood.V108.11.3498.3498
Published: 2006
Journal Articles

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Clinical Trials & Observations
Frits van Rhee, Susann M. Szmania, Fenghuang Zhan, Sushil K. Gupta, Mindy Pomtree, Pei Lin, Ramesh B. Batchu, Amberly Moreno, Guilio Spagnoli, John Shaughnessy, Guido Tricot
Journal: Blood
Blood (2005) 105 (10): 3939–3944.
https://doi.org/10.1182/blood-2004-09-3707
Published: 2005
Journal Articles

KIR-LIGAND Mismatched Natural Killer Cells Effectively Kill Primary Myeloma and Myeloma Cell Lines.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, JuMei Shi, MD, PhD, Michele Cottler-Fox, MD, Justin W. Dyniewski, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2449.
https://doi.org/10.1182/blood.V104.11.2449.2449
Published: 2004
Journal Articles

NY-ESO-1 Specific T-Cells Are Spontaneously Present in High-Risk Myeloma and Kill Primary Myeloma Cells.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Amberly Moreno, BS, Ramesh Batchu, PhD, Mindy Pomtree, BS, Nancy Rosen, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido J. Trico, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2454.
https://doi.org/10.1182/blood.V104.11.2454.2454
Published: 2004
Journal Articles

NY-ESO-1 Specific Antibodies Are Frequently Detected in Hight-Risk Myeloma.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, Mindy Pomtree, Frank Zhan, Amberly Moreno, BS, Nancy Rosen, Michele Fox, MD, Bart Barlogie, MD, PhD, John Shaughnessy, PhD, Ramesh Batchu, PhD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2464.
https://doi.org/10.1182/blood.V104.11.2464.2464
Published: 2004